FDA warning letter
Issue date
2 Aug 2019
Issuing office
Division of Pharmaceutical Quality Operations I
Posted date
10 Sept 2019
Subject
Drug Product/Adulterated
Products & Services
Drugs
Sharp
Distributor
Audited
Warning letter
Headquarters
NetherlandsSites
United States of America
United Kingdom
Ireland